Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between CCCL IPO and Saamya Biotech IPO.
CCCL IPO is a Mainline Fixed Price Issue IPO proposed to list at BSE, NSE while Saamya Biotech IPO is a Mainline Fixed Price Issue proposed to list at BSE.
| CCCL IPO | Saamya Biotech IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Fixed Price Issue |
| Listing At | BSE, NSE | BSE |
| Lead Managers | Axis Capital Limited Kotak Mahindra Capital Company Limited |
Uti Securities Ltd |
| Registrar | Kfin Technologies Limited | Aarthi Consultants Pvt Ltd. |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of CCCL IPO is up to ₹188.70 Cr whereas the issue size of the Saamya Biotech IPO is up to ₹15.00 Cr. The final issue price of CCCL IPO is ₹510.00 per share and of Saamya Biotech IPO is ₹10.00 per share.
| CCCL IPO | Saamya Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹460.00 per share | |
| Issue Price (Upper) | ₹510.00 per share | |
| Issue Price (Final) | ₹510.00 per share | ₹10.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 12 shares | 500 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 37,00,000 shares | 1,50,00,000 shares |
| Issue Size Total (Amount) | up to ₹188.70 Cr | up to ₹15.00 Cr |
CCCL IPO opens on Sep 18, 2007, while Saamya Biotech IPO opens on Sep 25, 2007. The closing date of CCCL IPO and Saamya Biotech IPO is Sep 21, 2007, and Sep 28, 2007, respectively.
| CCCL IPO | Saamya Biotech IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 18, 2007 | Sep 25, 2007 |
| Issue Close | Sep 21, 2007 | Sep 28, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
CCCL IPO P/E ratio is , as compared to Saamya Biotech IPO P/E ratio of .
| CCCL IPO | Saamya Biotech IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | 55.81% | 100% |
| Promoter Shareholding (Post-Issue) | 50.21% | 35% |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 25.6%% |
In the CCCL IPO retail investors (RII) are offered while in Saamya Biotech IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in CCCL IPO and in Saamya Biotech IPO.
| CCCL IPO | Saamya Biotech IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
CCCL IPO subscribed 81.18x in total, whereas Saamya Biotech IPO subscribed .
| CCCL IPO | Saamya Biotech IPO | |
|---|---|---|
| QIB (times) | 117.68x | |
| NII (times) | 67.62x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 12.69x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 81.18x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
